HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José Alvarez-Sabín Selected Research

triflusal

1/2014Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
1/2009Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
4/2003Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José Alvarez-Sabín Research Topics

Disease

53Stroke (Strokes)
08/2016 - 06/2002
28Ischemic Stroke
08/2016 - 12/2002
6Brain Ischemia (Cerebral Ischemia)
10/2014 - 01/2003
6Infarction (Infarctions)
07/2014 - 06/2002
5Inflammation (Inflammations)
10/2014 - 01/2005
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2014 - 07/2005
5Transient Ischemic Attack
01/2012 - 04/2003
4Hemorrhage
01/2014 - 02/2003
4Cerebral Hemorrhage
01/2014 - 07/2003
4Diabetes Mellitus
01/2013 - 05/2003
4Brain Injuries (Brain Injury)
12/2010 - 07/2005
3Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2014 - 09/2004
3Atherosclerosis
01/2012 - 01/2005
3Pathologic Constriction (Stenosis)
09/2011 - 01/2005
3Embolic Stroke
07/2010 - 02/2004
3Hyperglycemia
08/2005 - 05/2003
2Hypertension (High Blood Pressure)
04/2014 - 02/2014
2Atrial Fibrillation
04/2014 - 08/2008
2Ischemia
09/2013 - 02/2003
2Infections
01/2013 - 01/2011
2Cardiovascular Diseases (Cardiovascular Disease)
01/2012 - 09/2011
2Intracranial Arteriosclerosis (Cerebral Atherosclerosis)
01/2005 - 01/2005
2Cerebral Infarction
04/2003 - 01/2003
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
10/2013
1Brain Infarction
10/2013
1Cognitive Dysfunction
09/2013
1Hyperlipidemias (Hyperlipidemia)
01/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2011
1Neuroinflammatory Diseases
12/2010
1Telangiectasis (Telangiectasia)
05/2010
1Disease Progression
10/2008

Drug/Important Bio-Agent (IBA)

27Tissue Plasminogen Activator (Alteplase)FDA Link
10/2014 - 06/2002
9Biomarkers (Surrogate Marker)IBA
07/2014 - 10/2005
7Matrix Metalloproteinases (MMPs)IBA
06/2009 - 02/2003
5Cytidine Diphosphate Choline (Citicoline)IBA
08/2016 - 12/2002
4Proteins (Proteins, Gene)FDA Link
06/2009 - 07/2003
4C-Reactive ProteinIBA
05/2008 - 10/2003
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2006 - 02/2003
3Pharmaceutical PreparationsIBA
08/2016 - 01/2006
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2014 - 04/2003
3triflusalIBA
01/2014 - 04/2003
3CytokinesIBA
01/2013 - 11/2009
3EndostatinsIBA
05/2011 - 01/2005
3Plasminogen Activator Inhibitor 1IBA
05/2006 - 06/2004
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2014 - 04/2003
2Therapeutic UsesIBA
09/2013 - 07/2010
21-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2012 - 09/2011
2ChemokinesIBA
12/2010 - 01/2009
2Metalloproteases (Metalloproteinases)IBA
01/2009 - 07/2005
2Lipoprotein(a)IBA
05/2008 - 01/2005
2danaparoid (Orgaran)FDA Link
12/2007 - 02/2004
2Fibrinogen (Factor I)FDA Link
09/2006 - 05/2006
2Neuroprotective AgentsIBA
01/2006 - 12/2002
2Glucose (Dextrose)FDA LinkGeneric
08/2005 - 05/2003
2ImmunosorbentsIBA
07/2003 - 04/2003
2EnzymesIBA
07/2003 - 04/2003
1chitotriosidaseIBA
10/2014
14-(fluoromethyl)phenyl phosphate (FMPP)IBA
02/2014
1CreatinineIBA
10/2013
1AlbuminsIBA
10/2013
1Complement System Proteins (Complement)IBA
09/2013
1Interleukin-13IBA
01/2013
1InterferonsIBA
01/2013
1RNA (Ribonucleic Acid)IBA
05/2012
15'-palmitoyl cytarabine (PLAC)IBA
09/2011
1Becaplermin (PDGF-BB)FDA Link
05/2011
1erucylphosphocholineIBA
12/2010
1Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2010
1carbamylhydrazine (semicarbazide)IBA
07/2010
1human AOC3 proteinIBA
07/2010
1EndoglinIBA
05/2010
1Activin Receptors (Activin Receptor)IBA
05/2010
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2009
1AnticoagulantsIBA
01/2009
1Serine Proteases (Serine Protease)IBA
01/2009
1Protein CIBA
01/2009
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
01/2009
1contrast agent BR1IBA
10/2008
1SHU 508 (Levovist)IBA
10/2008
1Galactose (Galactopyranose)FDA LinkGeneric
10/2008
1Receptor for Advanced Glycation End ProductsIBA
08/2008
1fibrin fragment D (D-dimer)IBA
08/2008
1fas Receptor (CD95 Antigen)IBA
06/2008
1Fas Ligand Protein (Fas Ligand)IBA
06/2008
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2008
1E-SelectinIBA
05/2008
1Plasminogen Activators (Plasminogen Activator)IBA
05/2008

Therapy/Procedure

11Therapeutics
04/2014 - 01/2003
4Secondary Prevention
01/2014 - 08/2008
4Thrombolytic Therapy
06/2010 - 07/2005
4Time-to-Treatment
10/2008 - 09/2004
3Endovascular Procedures
07/2014 - 09/2013
2Thrombectomy
03/2014 - 01/2013
2Microbubbles
10/2008 - 02/2006
1Punctures
04/2014
1Stents
03/2014
1Activities of Daily Living (ADL)
09/2013
1Vascular Surgical Procedures
07/2009
1Neurological Rehabilitation
07/2009
1Lasers (Laser)
06/2009